Abstract
Interleukin (IL)-23 and IL-27 are IL-6/IL-12 family members that play a role in the regulation of T helper 1 cell differentiation. Cytokines are known to be involved in the bone remodeling process, although the effects of IL-23 and IL-27 have not been clarified. In this study, we examined the possible roles of these cytokines on osteoblast phenotypes and osteoclastogenesis. We found that IL-27 induced signal transducers and activators of transcription 3 activation in osteoblasts. However, neither IL-23 nor IL-27 showed any significant effects on alkaline phosphatase activity, receptor activator of nuclear factor κB ligand (RANKL) expression, mRNA expression such as alkaline phosphatase type I procollagen, or the proliferation of osteoblasts. Osteoclastogenesis from bone marrow cells induced by soluble RANKL was partially inhibited by IL-23 and IL-27 with reduced multinucleated cell numbers, but these interleukins did not affect the proliferation of osteoclast progenitor cells. These results indicate that IL-23 and IL-27 could partly modify cell fusion or the survival of multinucleated osteoclasts. On the other hand, partially purified T cells, which are activated by 2 µg/ml anti-CD3 antibody, completely inhibited osteoclastogenesis by M-CSF/RANKL. On using T cells activated with 0.2 µg/ml anti-CD3 antibody, in which osteoclastogenesis was partially inhibited, the interleukins had additive effects for inhibiting osteoclastogenesis. Although the consequences of phosphorylated signals in osteoblasts have not been identified, IL-23 and IL-27, partly and indirectly through activated T cells, inhibited osteoclastogenesis, indicating that these interleukins may protect against bone destructive autoimmune disorders.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
P Palmqvist E Persson HH Conaway UH Lerner (2002) ArticleTitleIL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae J Immunol 169 3353–3362 Occurrence Handle12218157 Occurrence Handle1:CAS:528:DC%2BD38XntFags70%3D
T Nakashima Y Kobayashi S Yamasaki A Kawakami K Eguchi H Sasaki H Sakai (2000) ArticleTitleProtein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines Biochem Biophys Res Commun 275 768–775 Occurrence Handle10973797 Occurrence Handle10.1006/bbrc.2000.3379 Occurrence Handle1:CAS:528:DC%2BD3cXmtFGlsL8%3D
CA O'Brien I Gubrij SC Lin RL Saylors SC Manolagas (1999) ArticleTitleSTAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1, but not 1,25-dihydroxyvitamin D3 or parathyroid hormone J Biol Chem 274 19301–19308 Occurrence Handle10383440 Occurrence Handle10.1074/jbc.274.27.19301
S Pflanz JC Timans J Cheung R Rosales H Kanzler et al. (2002) ArticleTitleIL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells Immunity 16 779–790 Occurrence Handle12121660 Occurrence Handle10.1016/S1074-7613(02)00324-2 Occurrence Handle1:CAS:528:DC%2BD38XltF2gtbs%3D
S Pflanz L Hibbert J Mattson R Rosales E Vaisberg JF Bazan JH Phillips TK McClanahan R de Waal Malefyt RA Kastelein (2004) ArticleTitleWSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27 J Immunol 172 2225–2231 Occurrence Handle14764690 Occurrence Handle1:CAS:528:DC%2BD2cXpslWmtw%3D%3D
A Takeda S Hamano A Yamanaka T Hanada T Ishibashi TW Mak A Yoshimura H Yoshida (2003) ArticleTitleCutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment J Immunol 170 4886–4890 Occurrence Handle12734330 Occurrence Handle1:CAS:528:DC%2BD3sXjsVGqsr8%3D
L Hibbert S Pflanz R De Waal Malefyt RA Kastelein (2003) ArticleTitleIL-27 and IFN-α signal via Stat1 and Stat3 and induce T-Bet and IL-12Rβ2 in naive T cells J Interferon Cytokine Res 23 513–522 Occurrence Handle14565860 Occurrence Handle10.1089/10799900360708632 Occurrence Handle1:CAS:528:DC%2BD3sXnsF2ntbk%3D
S Kamiya T Owaki N Morishima F Fukai J Mizuguchi T Yoshimoto (2004) ArticleTitleAn indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells J Immunol 173 3871–3877 Occurrence Handle15356135 Occurrence Handle1:CAS:528:DC%2BD2cXnsVWks7k%3D
N Morishima T Owaki M Asakawa S Kamiya J Mizuguchi T Yoshimoto (2005) ArticleTitleAugmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27 J Immunol 175 1686–1693 Occurrence Handle16034109 Occurrence Handle1:CAS:528:DC%2BD2MXmtlWjtb0%3D
M Hisada S Kamiya K Fujita ML Belladonna T Aoki Y Koyanagi J Mizuguchi T Yoshimoto (2004) ArticleTitlePotent antitumor activity of interleukin-27 Cancer Res 64 1152–1156 Occurrence Handle14871851 Occurrence Handle10.1158/0008-5472.CAN-03-2084 Occurrence Handle1:CAS:528:DC%2BD2cXhtFCgtrk%3D
R Salcedo J Stauffer E Lincoln T Back J Hixon C Hahn K Shafer-Weaver A Malyguine R Kastelein J Wigginton (2004) ArticleTitleIL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells J Immunol 173 7170–7182 Occurrence Handle15585838 Occurrence Handle1:CAS:528:DC%2BD2cXhtVCqur7L
M Shimizu M Shimamura T Owaki M Asakawa K Fujita M Kudo Y Iwakura Y Takeda AD Luster J Mizuguchi T Yoshimoto (2006) ArticleTitleAntiangiogenic and antitumor activities of IL-27 J Immunol 176 7317–7324 Occurrence Handle16751375 Occurrence Handle1:CAS:528:DC%2BD28Xlt1Clurs%3D
J Stumhofer A Laurence E Wilson E Huang C Tato L Johnson A Villarino Q Huang A Yoshimura D Sehy C Saris J O'Shea L Hennighausen M Ernst C Hunter (2006) ArticleTitleInterleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system Nat Immunol 7 937–945 Occurrence Handle16906166 Occurrence Handle10.1038/ni1376 Occurrence Handle1:CAS:528:DC%2BD28XotlCitbs%3D
M Batten J Li S Yi N Kljavin D Danilenko S Lucas J Lee SF de N Ghilardi (2006) ArticleTitleInterleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells Nat Immunol 7 929–936 Occurrence Handle16906167 Occurrence Handle10.1038/ni1375 Occurrence Handle1:CAS:528:DC%2BD28XotlCitbo%3D
S Kotake N Udagawa N Takahashi K Matsuzaki K Itoh S Ishiyama S Saito K Inoue N Kamatani M Gillespie T Martin T Suda (1999) ArticleTitleIL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis J Clin Invest 103 1345–1352 Occurrence Handle10225978 Occurrence Handle1:CAS:528:DyaK1MXivFans7c%3D Occurrence Handle10.1172/JCI5703
S Aggarwal N Ghilardi M Xie SF de A Gurney (2003) ArticleTitleInterleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 J Biol Chem 278 1910–1914 Occurrence Handle12417590 Occurrence Handle10.1074/jbc.M207577200 Occurrence Handle1:CAS:528:DC%2BD3sXisFyksA%3D%3D
B Oppmann R Lesley B Blom J Timans Y Xu et al. (2000) ArticleTitleNovel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 Immunity 13 715–725 Occurrence Handle11114383 Occurrence Handle10.1016/S1074-7613(00)00070-4 Occurrence Handle1:CAS:528:DC%2BD3cXovV2ht7c%3D
C Parham M Chirica J Timans E Vaisberg M Travis et al. (2002) ArticleTitleA receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R J Immunol 168 5699–5708 Occurrence Handle12023369 Occurrence Handle1:CAS:528:DC%2BD38XktFCrtrw%3D
M Matsui O Moriya ML Belladonna S Kamiya FA Lemonnier T Yoshimoto T Akatsuka (2004) ArticleTitleAdjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice J Virol 78 9093–9104 Occurrence Handle15308705 Occurrence Handle10.1128/JVI.78.17.9093-9104.2004 Occurrence Handle1:CAS:528:DC%2BD2cXntVKiu70%3D
A Borton J Frederick M Datto X Wang R Weinstein (2001) ArticleTitleThe loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis J Bone Miner Res 16 1754–1764 Occurrence Handle11585338 Occurrence Handle10.1359/jbmr.2001.16.10.1754 Occurrence Handle1:CAS:528:DC%2BD3MXnsVKqt78%3D
N Takahashi H Yamana S Yoshiki G Roodman G Mundy S Jones A Boyde T Suda (1988) ArticleTitleOsteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures Endocrinology 122 1373–1382 Occurrence Handle3345718 Occurrence Handle1:CAS:528:DyaL1cXhvVSqs74%3D Occurrence Handle10.1210/endo-122-4-1373
A Jeevan T Yoshimura KE Lee DN McMurray (2003) ArticleTitleDifferential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination Infect Immun 71 354–364 Occurrence Handle12496185 Occurrence Handle10.1128/IAI.71.1.354-364.2003 Occurrence Handle1:CAS:528:DC%2BD3sXhvVCqtg%3D%3D
R Nishimura K Moriyama K Yasukawa G Mundy T Yoneda (1998) ArticleTitleCombination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells J Bone Miner Res 13 777–785 Occurrence Handle9610741 Occurrence Handle10.1359/jbmr.1998.13.5.777 Occurrence Handle1:CAS:528:DyaK1cXjsVaqur0%3D
H Takayanagi K Ogasawara S Hida T Chiba S Murata K Sato A Takaoka T Yokochi H Oda K Tanaka K Nakamura T Taniguchi (2000) ArticleTitleT-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ Nature 408 600–605 Occurrence Handle11117749 Occurrence Handle10.1038/35046102 Occurrence Handle1:CAS:528:DC%2BD3cXovFajs7c%3D
T Yoshimoto K Okada N Morishima S Kamiya T Owaki M Asakawa Y Iwakura F Fukai J Mizuguchi (2004) ArticleTitleInduction of IgG2a class switching in B cells by IL-27 J Immunol 173 2479–2485 Occurrence Handle15294962 Occurrence Handle1:CAS:528:DC%2BD2cXmt1Oltrk%3D
M Afkarian J Sedy J Yang N Jacobson N Cereb S Yang T Murphy K Murphy (2002) ArticleTitleT-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells Nat Immunol 3 549–557 Occurrence Handle12006974 Occurrence Handle10.1038/ni794 Occurrence Handle1:CAS:528:DC%2BD38XjvFOmsbo%3D
M Meraz J White K Sheehan E Bach S Rodig A Dighe D Kaplan J Riley A Greenlund D Campbell K Carver-Moore R DuBois R Clark M Aguet R Schreiber (1996) ArticleTitleTargeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK–STAT signaling pathway Cell 84 431–442 Occurrence Handle8608597 Occurrence Handle10.1016/S0092-8674(00)81288-X Occurrence Handle1:CAS:528:DyaK28XhtFWqtrc%3D
W Xu J Zhang (2005) ArticleTitleStat1-dependent synergistic activation of T-bet for IgG2a production during early stage of B cell activation J Immunol 175 7419–7424 Occurrence Handle16301649 Occurrence Handle1:CAS:528:DC%2BD2MXht1ent7%2FL
T Owaki M Asakawa S Kamiya K Takeda F Fukai J Mizuguchi T Yoshimoto (2006) ArticleTitleIL-27 suppresses CD28-mediated IL-2 production through suppressor of cytokine signaling 3 J Immunol 176 2773–2780 Occurrence Handle16493033 Occurrence Handle1:CAS:528:DC%2BD28Xhs1ert7o%3D
J Moreno M Kaczmarek A Keegan M Tondravi (2003) ArticleTitleIL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL Blood 102 1078–1086 Occurrence Handle12689929 Occurrence Handle10.1182/blood-2002-11-3437 Occurrence Handle1:CAS:528:DC%2BD3sXlvFCmtLw%3D
N Udagawa N Horwood J Elliott A Mackay J Owens H Okamura M Kurimoto T Chambers T Martin M Gillespie (1997) ArticleTitleInterleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation J Exp Med 185 1005–1012 Occurrence Handle9091574 Occurrence Handle10.1084/jem.185.6.1005 Occurrence Handle1:CAS:528:DyaK2sXhvFags70%3D
S Yogesha S Khapli M Wani (2005) ArticleTitleInterleukin-3 and granulocyte–macrophage colony-stimulating factor inhibits tumor necrosis factor (TNF)-α-induced osteoclast differentiation by down-regulation of expression of TNF receptors 1 and 2 J Biol Chem 280 11759–11769 Occurrence Handle15653694 Occurrence Handle10.1074/jbc.M410828200 Occurrence Handle1:CAS:528:DC%2BD2MXisVyjtb4%3D
N Kim Y Kadono M Takami J Lee S Lee F Okada J Kim T Kobayashi P Odgren H Nakano W Yeh S Lee J Lorenzo Y Choi (2005) ArticleTitleOsteoclast differentiation independent of the TRANCE–RANK–TRAF6 axis J Exp Med 202 589–595 Occurrence Handle16147974 Occurrence Handle10.1084/jem.20050978 Occurrence Handle1:CAS:528:DC%2BD2MXhtVSjs7zM
T Koga M Inui K Inoue S Kim A Suematsu E Kobayashi T Iwata H Ohnishi T Matozaki T Kodama T Taniguchi H Takayanagi T Takai (2004) ArticleTitleCostimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis Nature 428 758–763 Occurrence Handle15085135 Occurrence Handle10.1038/nature02444 Occurrence Handle1:CAS:528:DC%2BD2cXjtV2mt78%3D
Y Okada I Morimoto K Ura K Watanabe S Eto M Kumegawa L Raisz C Pilbeam Y Tanaka (2002) ArticleTitleCell-to-cell adhesion via intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 pathway is involved in 1alpha,25(OH)2D3, PTH and IL-1alpha-induced osteoclast differentiation and bone resorption Endocr J 49 483–495 Occurrence Handle12402981 Occurrence Handle10.1507/endocrj.49.483 Occurrence Handle1:CAS:528:DC%2BD38XosFSksb0%3D
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kamiya, S., Nakamura, C., Fukawa, T. et al. Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation. J Bone Miner Metab 25, 277–285 (2007). https://doi.org/10.1007/s00774-007-0766-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-007-0766-8